S'abonner

Does genetic regulation of IgE begin in utero? Evidence from TH1/TH2 gene polymorphisms and cord blood total IgE - 07/08/11

Doi : 10.1016/j.jaci.2010.08.029 
Xiumei Hong, MD, PhD a, , Hui-Ju Tsai, PhD a, c, , Xin Liu, MD, PhD a, , Lester Arguelles, PhD a, Rajesh Kumar, MD b, Guoying Wang, MD, PhD a, Nataliya Kuptsova-Clarkson, MD, PhD a, Colleen Pearson, BA d, Kathryn Ortiz, BA d, Anthony Bonzagni, BA d, Stephanie Apollon, BA d, Lingling Fu, MS d, Jacqueline A. Pongracic, MD b, Robert Schleimer, PhD e, Patrick G. Holt, DSc f, Howard Bauchner, MD d, Xiaobin Wang, MD, MPH, ScD a,
a Mary Ann and J. Milburn Smith Child Health Research Program, Children’s Memorial Hospital and Children’s Memorial Research Center, Chicago, Ill 
b Division of Allergy and Immunology, Children’s Memorial Hospital, Chicago, Ill 
c Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan 
d Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, Mass 
e Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill 
f Division of Cell Biology, Telethon Institute for Child Health Research, West Perth, Australia 

Reprint requests: Xiaobin Wang, MD, MPH, ScD, Professor and Director, Mary Ann and J. Milburn Smith Child Health Research Program, Children’s Memorial Hospital and Children’s Memorial Research Center, Northwestern University Feinberg School of Medicine, 2300 Children’s Plaza, Box 157, Chicago, IL 60614-3394.

Abstract

Background

Elucidation of early life factors is critical to understand the development of allergic diseases, especially those manifesting in early life such as food allergies and atopic dermatitis. Cord blood IgE (CBIgE) is a recognized risk factor for the subsequent development of allergic diseases. In contrast with numerous genetic studies of total serum IgE in children and adults, limited genetic studies on CBIgE have been conducted.

Objective

To test the associations between functional or tagging single nucleotide polymorphisms (SNPs) in genes involved in the TH1/TH2 pathway and CBIgE in a large US inner-city birth cohort.

Methods

CBIgE, measured by Phadia ImmnunoCAP, was analyzed as a continuous and a binary variable. The association of each SNP with the 2 outcomes was tested using tobit and logistic regression models, respectively, with adjustment for pertinent covariates, ancestral proportion, and multiple testing. Ethnic heterogeneity and gene-gene interactions were also explored.

Results

Three SNPs (rs1800925, rs2069743, and rs1295686) in the IL13 gene were significantly associated with CBIgE concentration (P ≤ 6 × 10−4, FDR-corrected P < .05). These SNPs jointly influenced CBIgE in a dose-response manner (P for trend = 9 × 10−8). Significant associations also were observed for SNPs in the IL-13 receptor ⍺1 (rs5956080) and signal transducer and activator of transcription 6 (rs11172106) genes. Ethnicity-specific genetic effects were observed for SNPs in the IL5 and GATA3 genes. Several gene-gene interactions (including IL13–IL4 receptor and IL13–signal transducer and activator of transcription 6 interactions) were detected in relation to CBIgE.

Conclusion

Our data demonstrated that multiple SNPs were individually and jointly associated with CBIgE, with evidence of gene-gene interactions and ethnic heterogeneity. These findings suggest that genetic regulation of IgE may begin in utero.

Le texte complet de cet article est disponible en PDF.

Key words : Genetic association, candidate gene, cord blood IgE, gene-gene interaction

Abbreviations used : BMI, CBIgE, CMH, FDR, FOXP3, FS, HWE, IL4R, IL5RA, IL13RA1, JAK, LD, MAF, OR, SNP, STAT6, Treg


Plan


 The parent study is supported in part by the March of Dimes PERI grants (PI: X.W., 20-FY02-56), NIEHS (PI: X.W., R21 ES011666), and NICHD (PI: X.W., R01 HD041702). The follow-up study is supported in part by the Food Allergy Initiative and NIAID (PI: X.W., R21AI079872). R.K. is supported by the NHLBI (K23HL093023). X.L. has been supported by a career development award from the National Institutes of Health/Clinical and Translational Science Awards Program, Northwestern University (KL2RR025740). X.L. also is supported by an NIAID grant (R21AI087888).
 Disclosure of potential conflict of interest: R. Kumar has received research support from the National Heart, Lung, and Blood Institute. J. A. Pongracic has received research support from the National Institute of Allergy and Infectious Diseases and the Food Allergy Project. R. Schleimer has received research support from the National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.


© 2010  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 126 - N° 5

P. 1059 - novembre 2010 Retour au numéro
Article précédent Article précédent
  • Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu
  • Amanda J. Reefer, Kathryn E. Hulse, Josephine A. Lannigan, Michael D. Solga, Paul W. Wright, Libby A. Kelly, James Patrie, Martin D. Chapman, Judith A. Woodfolk
| Article suivant Article suivant
  • The T-cell response to Amb a 1 is characterized by 3 dominant epitopes and multiple MHC restriction elements
  • Beatrice Jahn-Schmid, Nicole Wopfner, Gudrun Hubinger, Riccardo Asero, Christof Ebner, Fatima Ferreira, Barbara Bohle

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.